- Home
- CCIF vs SEER Comparison
CCIF vs SEER Comparison
Compare CCIF & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIF
- SEER
- Stock Information
- Founded
- CCIF 2011
- SEER 2017
- Country
- CCIF United States
- SEER United States
- Employees
- CCIF N/A
- SEER N/A
- Industry
- CCIF Finance/Investors Services
- SEER Medicinal Chemicals and Botanical Products
- Sector
- CCIF Finance
- SEER Health Care
- Exchange
- CCIF Nasdaq
- SEER Nasdaq
- Market Cap
- CCIF 110.4M
- SEER 113.8M
- IPO Year
- CCIF N/A
- SEER 2020
- Fundamental
- Price
- CCIF $5.17
- SEER $2.01
- Analyst Decision
- CCIF
- SEER
- Analyst Count
- CCIF 0
- SEER 0
- Target Price
- CCIF N/A
- SEER N/A
- AVG Volume (30 Days)
- CCIF 76.9K
- SEER 112.0K
- Earning Date
- CCIF 01-01-0001
- SEER 11-06-2025
- Dividend Yield
- CCIF 25.90%
- SEER N/A
- EPS Growth
- CCIF N/A
- SEER N/A
- EPS
- CCIF N/A
- SEER N/A
- Revenue
- CCIF N/A
- SEER $16,376,999.00
- Revenue This Year
- CCIF N/A
- SEER $25.97
- Revenue Next Year
- CCIF N/A
- SEER $24.00
- P/E Ratio
- CCIF N/A
- SEER N/A
- Revenue Growth
- CCIF N/A
- SEER 12.11
- 52 Week Low
- CCIF $7.43
- SEER $1.62
- 52 Week High
- CCIF $10.16
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- CCIF 37.21
- SEER 34.40
- Support Level
- CCIF $5.13
- SEER $2.05
- Resistance Level
- CCIF $5.27
- SEER $2.29
- Average True Range (ATR)
- CCIF 0.09
- SEER 0.08
- MACD
- CCIF 0.01
- SEER -0.02
- Stochastic Oscillator
- CCIF 19.23
- SEER 4.05
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.